KK
Kramer Kelly A.
Director
OFFICERF
Insider track record
ExecutiveNot enough buy signals with a settled T+90 horizon to measure a track record yet.
Discover the full record of transactions filed by Kramer Kelly A., Director. Director active across 5 companies, notably Gilead Sciences, INC.. Cumulatively, 16 disclosures have been recorded. Activity tracked since 8 July 2021. The latest transaction was filed on 2 June 2026 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Kramer Kelly A.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations16 total
1,268 sharesClass A Common StockSEC:0001679788-26-000070:0
12,415 shares0Class A Common StockSEC:0001629885-26-000004:0
2,756 shares0Class A Common StockSEC:0001629885-25-000007:0
2,806 shares@ US$81.000.0001% mcap50.0% of flowCommon StockSEC:0001629885-25-000005:0
1,373 shares0Common StockSEC:0001640147-25-000154:0
1,533 shares0Class A Common StockSEC:0001679788-25-000122:0
2,292 shares0Class A Common StockSEC:0001640147-24-000191:0
6,294 shares0Class A Common StockSEC:0001679788-24-000117:0
1,695 shares0Class A Common StockSEC:0001640147-23-000154:0
5,199 shares0Class A Common StockSEC:0001679788-23-000086:0
9,670 shares0Class A Common StockSEC:0001679788-23-000034:0
2,217 shares0Class A Common StockSEC:0001640147-22-000070:0
1,270 shares0Class A Common StockSEC:0001679788-22-000059:0
9,671 shares0Class A Common StockSEC:0001679788-22-000017:0
1,224 shares0Class A Common StockSEC:0001640147-21-000166:0
29,370 sharesCommon StockSEC:0001140361-16-052427:0
About Kramer Kelly A.
Kelly A. Kramer is a Director of GILEAD SCIENCES, INC., Snowflake Inc., and Coinbase Global, Inc. She plays a key role in the strategic direction of these companies, ensuring that decisions made align with growth and innovation objectives.